For the year ending 2025-12-31, RXST made $134,479K in revenue. -$39,057K in net income. Net profit margin of -29.04%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Sales | 134,479 | - | ||
| Cost of sales | 31,470 | - | ||
| Gross profit | 103,009 | 98,943 | ||
| Selling, general and administrative | 112,651 | 101,434 | ||
| Research and development | 38,549 | 34,367 | ||
| Total operating expenses | 151,200 | 135,801 | ||
| Loss from operations | -48,191 | -36,858 | ||
| Interest expense | 19 | 21 | ||
| Interest and other income | 9,332 | 9,474 | ||
| Loss on extinguishment of term loan | 0 | - | ||
| Loss before income taxes | -38,878 | -27,405 | ||
| Income tax expense | 66 | 50 | ||
| Net loss | -38,944 | -27,455 | ||
| Unrealized (loss) gain on short-term investments | -136 | 180 | ||
| Foreign currency translation gain (loss) | 23 | -9 | ||
| Total other comprehensive (loss) income | -113 | 171 | ||
| Comprehensive loss | -39,057 | -27,284 | ||
| Basic EPS | -0.95 | -0.71 | ||
| Diluted EPS | -0.95 | -0.71 | ||
| Basic Average Shares | 40,850,739 | 38,867,726 | ||
| Diluted Average Shares | 40,850,739 | 38,867,726 | ||
RxSight, Inc. (RXST)
RxSight, Inc. (RXST)